Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Federico

Showing results (1-10 of 271) with videos related to

Pageof 28
Sort By:
Hematological Oncology|March 4, 2006
Prognosis of follicular lymphomasStefano Luminari, Massimo Federico
Haematologica|April 2, 2019
The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective International T-Cell ProjectMonica Bellei, Massimo Federico
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2013
Reply to R.L. Olin et alMassimo Federico, Alessandra Dondi
Hematology Reports|May 16, 2012
Case studies of elderly patients with non-Hodgkin's lymphomaStefano Luminari, Massimo Federico
Haematologica|July 3, 2025
BTKi +humanized anti-CD20 for advanced follicular lymphoma: ready for an ALTERNATIVE?Irene Dogliotti, Massimo Federico
Leukemia & Lymphoma|November 17, 2006
The role of anthracyclines in follicular lymphomasStefano Luminari, Massimo Federico
Critical Reviews in Oncology/Hematology|May 20, 2011
What has happened to VBM (vinblastine, bleomycin, and methotrexate) chemotherapy for early-stage Hodgkin lymphoma?Paolo G Gobbi, Massimo Federico
The New England Journal of Medicine|September 8, 2016
Interim PET-CT Scan in Advanced Hodgkin's LymphomaPeter Johnson, Judith Trotman, Massimo Federico
The Lancet. Haematology|December 6, 2016
Time to publish: challenging the performance of cooperative group lymphoma trialsMassimo Federico, Judith Trotman, Martin Dreyling
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2022
Reply to M. Shibusawa et alStefano Luminari, Luca Arcaini, Massimo Federico
Pageof 28

Showing results (1-10 of 271) with videos related to

Sort By:
Pageof 28
Hematological Oncology|March 4, 2006
Prognosis of follicular lymphomasStefano Luminari, Massimo Federico
Haematologica|April 2, 2019
The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective International T-Cell ProjectMonica Bellei, Massimo Federico
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2013
Reply to R.L. Olin et alMassimo Federico, Alessandra Dondi
Hematology Reports|May 16, 2012
Case studies of elderly patients with non-Hodgkin's lymphomaStefano Luminari, Massimo Federico
Haematologica|July 3, 2025
BTKi +humanized anti-CD20 for advanced follicular lymphoma: ready for an ALTERNATIVE?Irene Dogliotti, Massimo Federico
Leukemia & Lymphoma|November 17, 2006
The role of anthracyclines in follicular lymphomasStefano Luminari, Massimo Federico
Critical Reviews in Oncology/Hematology|May 20, 2011
What has happened to VBM (vinblastine, bleomycin, and methotrexate) chemotherapy for early-stage Hodgkin lymphoma?Paolo G Gobbi, Massimo Federico
The New England Journal of Medicine|September 8, 2016
Interim PET-CT Scan in Advanced Hodgkin's LymphomaPeter Johnson, Judith Trotman, Massimo Federico
The Lancet. Haematology|December 6, 2016
Time to publish: challenging the performance of cooperative group lymphoma trialsMassimo Federico, Judith Trotman, Martin Dreyling
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2022
Reply to M. Shibusawa et alStefano Luminari, Luca Arcaini, Massimo Federico
Pageof 28